Nayana Prabhu
Nayana Prabhu obtained her Master’s degree in Biochemistry from Bangalore University, India. She spent three years working in the R&D sector in the Biotech industry in India. Soon after, she worked in the Animal Biotechnology laboratory at Temasek Lifeciences Laboratory, Singapore, studying H5N1 influenza viruses. Nayana then joined the Immunology Program at the National University of Singapore to undertake a PhD in Immunology. Her interest in drug discovery drew her to the CETSA approach to study target engagement in the laboratory of Prof. Par Nordlund at Nanyang Technological University. Nayana now leads the MS-CETSA team at IMCB.
Liang Ying Yu
Ying Yu completed her undergraduate and postgraduate degrees in Molecular Biotechnology at the University of Applied Sciences Vienna and received her PhD from the Medical University of Vienna in 2016. Her work focussed on chemotherapy-induced immunogenic cell death as well as the effect of chemotherapy on the anti-tumour immune response in multiple myeloma patients. She then joined Par Nordlund’s group as a postdoctoral fellow at the Karolinska Institute Stockholm where she acquired her mass spectrometry (MS) skills and expertise in cellular thermal shift assay (CETSA). In 2020 she transferred to IMCB where she is currently working.
Le Hai Van
Hai Van obtained her BSc with Biochemistry major from Vietnam National University in 2013. She then received her MSc studies in Life Science at Gachon University (Korea) in 2015 and graduated with a PhD degree from National University of Singapore in 2021. During her PhD study, she focused on how to apply Pt-based chemo-agents to stimulate anticancer immune responses using macrophage model. She then has joined Par Nordlund’s group as a research fellow at IMCB, A-STAR where she can broaden her knowledge and experience with MS-CETSA.
Khalidah Khalid
Khalidah completed her Honours degree in Life Science from the National University of Singapore in 2020. Before joining the CETSA team, she was involved in the study of methylated genes in colorectal cancer with the use of droplet digital PCR. For her honours project, she performed the isolation and characterization of bacteriophages targeting Pseudomonas aeruginosa. Currently, she is a research officer in the Nordlund group where she is involved in the study of drug-target engagement using the MS-CETSA approach.
Our Lab is supported by..
